A Look Back at Jeffrey Ubben's Presentation at the 8th Annual New York Value Investing Congress
On October 2, 2012, ValueAct Capital's fearless leader Jeffrey Ubben made a presentation on Day 2 of the 8th Annual Value Investing Congress in New York.
Hedge Fund - ValueAct Capital
News, Interviews, and Investor Letters
- First
- << Previous
- 91 - 100
- Next >>
ValueAct Capital Increases Stake In Twenty-First Century Fox Inc (FOX)
Jeff Ubben’s ValueAct Capital increased its stake in Twenty-First Century Fox Inc (NASDAQ:FOX).
Jeffrey Ubben Has a Surprise Entry Among His Top Stock Picks
It is not every quarter that you get to spot drastic changes in the equity portfolio of Jeffrey Ubben's ValueAct Capital.
Activist Jeffrey Ubben's Picks Blow Away S&P 500 Index in Q1
Activist Jeffrey Ubben's 14 picks in companies with a market cap of $1 billion or more (his entire portfolio) delivered weighted average returns of 8.1% in the first quarter.
ValueAct Still Believes Strongly in Microsoft Corporation (MSFT): Here’s Why
In a Form 4 filing with the SEC yesterday, Jeffrey Ubben’s ValueAct Capital disclosed seven purchases of Microsoft Corporation (NASDAQ:MSFT) stock between February 2 and February 4, totaling slightly...
Msci Inc (MSCI) Agrees To Appoint ValueAct Capital’s Representatives To Board
A new filing with the U.S.
Baker Hughes Incorporated (BHI): ValueAct Reports Activist Stake as Company Reports Strong Financial Results
In a new filing with the Securities and Exchange Commission, Jeff Ubben's ValueAct Capital reported a new stake in the $25 billion oilfield services company Baker Hughes Incorporated (NYSE:BHI).
Msci Inc (MSCI): ValueAct's CEO Jeff Ubben Pushes for Board Seats; Says Has "Unanswered Questions"
In a new filing with the Securities and Exchange Commission, Jeff Ubben's ValueAct Capital has disclosed a letter sent to the Lead Director of the application software company Msci Inc (NYSE:MSCI) Rodolphe...
Adobe Systems Incorporated (ADBE): ValueAct Sells Some More Shares as Stock Surges on the Back of Strong Financial Results
A new filing with the Securities and Exchange Commission showed that Jeff Ubben's ValueAct Capital has reduced its stake in Adobe Systems Incorporated (NASDAQ:ADBE).
Valeant Pharmaceuticals Intl Inc (VRX): ValueAct Keeps Its Promise and Buys More Shares
In a new filing with the Securities and Exchange Commission, Jeff Ubben's ValueAct Capital reported increasing its position in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
- First
- << Previous
- 91 - 100
- Next >>